Novonesis AS

Director's Dealing • Jan 26, 2012

January 26, 2011

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

Name	Relation/ Category of close relation	Trading date	Character of transaction	Volume of transaction Buy (+) / Sell (-)	Value of trans action (DKK)
Benny D. Loft	EVP, and CFO	26/1/2012	Exercise of Options (purchase of shares)	+189,120	14,751,360

Contact persons:
Press and media:	Investor relations:
René Tronborg (Europe)	Martin Riise
Tel. (direct): +45 4446 2274
Tel. (mobile): +45 3077 2274

Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501

Martin Riise Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738

Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Krogshoejvej 36 2880 Bagsvaerd Denmark

Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27